trending Market Intelligence /marketintelligence/en/news-insights/trending/jsnjh56_n5d-1idwwoom0q2 content esgSubNav
In This List

Motif Bio board member resigns

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Motif Bio board member resigns

New York-based Motif Bio PLC said Robert Bertoldi will step down from its board, effective July 16.

Motif Bio is a clinical stage biopharmaceutical company that develops and sells pharmaceutical formulations in the U.S.